The purpose of this study was to examine the hepatocellular extraction of taurocholate and to determine the kinetic characteristics of the uptake process. The uptake of taurocholate by the liver of the intact dog was studied by the multiple-indicator dilution method. 51Cr-labeled red blood cells (a vascular indicator), 125I-labeled albumin (an extravascular reference), and [14C]taurocholate were injected into the portal vein. Different doses of unlabeled taurocholate were included in the injection mixture. Hepatic venous dilution curves were obtained. As a consequence of the hepatic uptake, the outflow recovery of [14C]taurocholate was much reduced when compared to that of albumin, but its recovery increased with increasing doses of taurocholate, suggesting a progressive saturation of the uptake process. The analysis of the dilution curves fitted a three-compartment model system well and no return of the extracted taurocholate to the extracellular space could be detected. The initial space of distribution of taurocholate was 1.22 plus or minus 0.12 (SD) times greater than that of albumin. Analysis of the data for uptake was consistent with MichaelisMenten kinetics. The calculated initial maximal velocity of uptake (Vmax) was 4.53 mumol times s--1 times 100 g of liver--1 and the dose yielding half-maximal velocity (DK) was 7.11 mumol times 100 g of liver--1. These results are consistent with the hypothesis that the uptake of taurocholate is carrier-mediated. A B S T R A C T The purpose of this study was to examine the hepatocellular extraction of taurocholate and to determine the kinetic characteristics of the uptake process. The uptake of taurocholate by the liver of the intact dog was studied by the multiple-indicator dilution method. 5'Cr-labeled red blood cells (a vascular indicator), MI-labeled albumin (an extravascular reference), and ["C]taurocholate were injected into the portal vein. Different doses of unlabeled taurocholate were included in the injection mixture. Hepatic venous dilution curves were obtained. As a consequence of the hepatic uptake, the outflow recovery of [1'C]taurocholate was much reduced when compared to that of albumin, but its recovery increased with increasing doses of taurocholate, suggesting a progressive saturation of the uptake process. The analysis of the dilution curves fitted a three-compartment model system well and no return of the extracted taurocholate to the extracellular space could be detected. The initial space of distribution of taurocholate was 1.22±0.12 (SD) times greater than that of albumin. Analysis of the data for uptake was consistent with Michaelis-Menten kinetics. The calculated initial maximal velocity of uptake (Vmax) was 4.53 umol * sl. 100 g of liver' and the dose yielding half-maximal velocity (KD) was 7.11 amolk 100 g of liver'. These results are consistent with the hypothesis that the uptake of taurocholate is carrier-mediated. The maximal velocity of uptake was about six times the known maximal capacity of biliary secretion of taurocholate in the dog.
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INTRODUCTION
Although it is generally assumed that the hepatic handling of bile acids consists of three steps (hepatic upThis work was presented in part at the 8th meeting of the European Association for the Study of the Liver, Vittel, France, 7-8 September 1973 and abstracted in Digestion. 8: 432-433. 1973 .
Received for publication 8 April 1974 and in revised form 16 October 1974. take, intracellular transport, and biliary excretion), the mechanism by which these organic anions are taken up by the liver is completely unknown. O'Maille, Richards, and Short have shown that in the dog the extraction of labeled taurocholate from plasma is about 90% during a single passage through the liver (1) . This efficiency of extraction is remarkable and greater than the hepatic extraction of sulfobromophthalein (BSP)1 (2) and most other compounds.
Goresky has studied the uptake of BSP by the liver of the dog and shown that this process was saturable, a finding consistent with the presence of a carrier-mediated transport system (3). The multiple-indicator dilution technique permitted an estimation of the maximal initial velocity of the transport process, and of the extravascular concentration yielding half-maximal initial velocity.
The high extraction efficiency of the liver for bile acids suggests an active or carrier-mediated transport system for these compounds. The purpose of this study was to examine the hepatocellular extraction of taurocholate and to determine the kinetic characteristics of the uptake process. A multiple-indicator dilution technique essentially similar to that used for BSP by Goresky was employed, assuming a flow-limited three-compartment model. The results are consistent with MichaelisMenten kinetics, and hence, with the existence of a carrier-mediated transport system.
METHODS

Experimental procedures
22 experiments were performed in 8 dogs (18-24 kg). The dogs were anesthetized with 1 mg/kg of 5% sodium pentobarbital2 and maintained under artificial respiration. A 0.15 M NaCl solution was infused into the femoral vein throughout the experiment at a rate of 0.2-0.5 ml/min. (5) . The mean transit times were measured by the procedure described by Meier and Zierler (5) and corrected by subtraction for the catheter transit times (6) . Zero time (t.), which corresponds to the time spent by the labels in the large vessels, where no exchange or removal took place, was calculated according to the formula (7) tAlb, the transit time at the peak of the labeled albumin dilution curve; y, the ratio of the extravascular distribution volume to the vascular distribution volume; and (1 + y) is computed as the ratio of the peak red cell concentration to the peak albumin concentration.
Kinetic analysis. The determinations of the removal rate constant, the hepatic taurocholate concentration, the initial removal rate, and the kinetic analysis were performed as indicated under results.
RESULTS
Mean transit times and plasma flows are shown in Table I. The outflow recovery of labeled red cells corresponds to 1.03±0.05 (SEM) times that of labeled albumin. Fig. 1 illustrates the outflow profile for an experiment carried out with a dose of taurocholate of 3.3 Amol/100 g of liver. The upper panel is rectilinear and the lower semilogarithmic. The red cell curve has the highest and earliest peak and then decays rapidly. The albumin curve has a lower and later peak and decays less quickly than that of red cells. The areas under both curves are equal when recirculation is excluded by extrapolation of the downslopes. The ['C]taurocholate emerges at the outflow at the same time as the 'I-labeled albumin, but when the taurocholate dilution curve was compared to that of albumin, two differences were noted: (a) the area of the taurocholate dilution curve was smaller than that of the albumin dilution curve; and (b) after the peak, the concentration of taurocholate decayed more rapidly than that of albumin, so that a progressive divergence between the two curves with time was apparent. difference of area between MI-labeled albumin and ["C]-taurocholate has decreased as the dose of taurocholate increased.
As can be seen in Table II , the fraction of the dose of taurocholate extracted in one passage through the liver roughly decreased as the dose of taurocholate increased. This suggests a progressive saturation of the uptake process.
To interpret the results in adequate terms for a kinetic analysis, the model originally proposed by Goresky for BSP (3) and modified as proposed by Goresky, Bach, and Nadeau (8) (1) where ki is the removal rate constant describing the Symbols are the same as in Fig. 1 . Note that the taurocholate curve is not contained within the area of the albumin curve: this is because albumin is not the correct reference in this case. The appropriate reference curve has been calculated as indicated in the text. The experiment illustrated is numbered 21 in the tables. ratio of the cellular space to the total space, vascular + extravascular, outside the cells.
In our study, where a single injection rather than a constant infusion was used, the cellular compartment may be viewed as virtually empty at the beginning of the experiment; the returning material may then be neglected and Eq. 1 transformed into: and which would be completely recovered in the outflow.
The graphic method of Goresky (3) was utilized to select the appropriate reference dilution curve and in consequence its space of distribution, and to determine the factor klO/(1 + '). The application of this graphic procedure is shown in Fig. 3 . In Fig. 3A (Fig. 4) .
The influence of the dose on the removal rate constant, kO, is shown in Fig. 5 ; kz0 decreased as the dose increased. Similarly, the influence of the dose on the factor k01/(1 + i) is shown in Fig. 6 ; this factor decreased as the dose increased.
The initial velocity of uptake increased nonlinearly with increasing doses of taurocholate, as shown in Fig.   7 . Michaelis-Menten kinetics were then assumed; the parameters of the Michaelis-Menten equation a substance excluded from liver cells in one passage, is larger than that available to albumin (7); as will be discussed later, the access of taurocholate to a larger distribution space than that of albumin suggests that this bile salt is not tightly bound to albumin. The theoretical dilution curves for progressively greater spaces of distribution have been obtained from the transformation of the albumin dilution curve, in agreement with the properties of the dilution curves of a flow-limited distributed substance (7) . From this set of theoretical dilution curves, the one whose concentrations maintained a single exponential ratio through time with the corresponding concentration of ["C]taurocholate was chosen. This new curve is represented in Fig. 3C, with (Fig. 3D) .
By this procedure the initial space of distribution and the removal rate constant, kO, for taurocholate were obtained in each experiment. The removal rate constant, k10, represents essentially the quotient of the PS product at the cellular surface to the plasma volume in the related sinusoid, P being the permeability in centimeters
where v is the initial velocity of uptake, D the dose of taurocholate per 100 g of liver, Vmax the maximal initial velocity of uptake, and KD the dose yielding halfmaximal velocity, were calculated in three ways: (a) by using a digital computer program to identify mathematically Vmax and KD; (b) after linear transformation of the data according to Woolf, when Eq. 3 has been taurocholate space albumin space 
The estimates of Vmax and KD obtained from the computer, from the Woolf linear transformation, and from the Lineweaver-Burk transformation are indicated on used (3, 7) .
The curves were not corrected for catheter distortion (10) : it has been shown that the influence of catheter distortion on this type of analysis was minimal (11) .
Distribution space of taurocholate. The space of distribution of taurocholate corresponded to a mean value of 1.22±0.12 (SD) times the distribution space of albumin. O'Maille, Richards, and Short have previously estimated a space of distribution for taurocholate greater than plasma volume (12) . In contrast, the space of distribution of BSP is the same as that of albumin (3) . This difference can be explained on the basis of the higher affinity of BSP for plasma albumin. In fact, the dissociation constant of the albumin-cholic acid complex calculated by Rudman and Kendall was 6.5 X 10-' (13), a much higher value than 5.8 X 10', the dissociation constant of the albumin-BSP complex obtained by Baker and Bradley (14) . Albumin has an apparently smaller immediately accessible space than the total extravascular space (7, 15) . Sodium and sucrose are also extracellular indicators and their space of distribution is about 1.6 times the space of distribution of albumin (7, 15) . Neither the proportion of the injected taurocholate dissociated from plasma albumin in the sinusoids nor the proportion of bile acids bound to albumin at normal plasma concentrations are known; therefore, it is only possible to assume that the calculated space of distribution of taurocholate is the algebraic sum of the space of a fraction bound to albumin (and so limited to the albumin space of distribution) and of the space of an unassociated fraction that diffuses instantaneously in the whole extravascular space. On this basis, if we assume a distribution space equal to that of albumin if completely bound, and a distribution space of 1.66 times that of albumin if completely unassociated, it is possible to estimate that approximately 60% of taurocholate would normally be bound to plasma albumin in the sinusoids. The space of distribution of taurocholate did not change with increasing doses, suggesting that the ratio of bound to un- bound taurocholate did not change significantly in the range of doses injected. Kinetic characteristics of the uptake process. It was apparent that the removal rate constant decreased (Fig.  5) and that the initial velocity of uptake increased (Fig.  7) both nonlinearly when the dose of taurocholate increased. This strongly suggests a saturation phenomenon, as discussed for BSP (3), and is one criterion used to support the hypothesis that the transport of a substance from the plasma into the liver cell is carrier-mediated. The uptake would then be expected to follow MichaelisMenten kinetics. Consistent with this view is the finding that, when the Woolf transformation was applied to the data, a highly significant linear correlation was found between D/k.6D (i.e. 1/k16) and D (Fig. 8) ; it is to be noted that the two terms of the correlation, namely 1/k16 and D, are computed independently.
The parameters of the kinetics Vmax (the maximal initial velocity of uptake) and KD (the dose yielding half-maximal velocity) were computed by mathematical identification with a computer program and from the linear transformations of Woolf and Lineweaver-Burk: the values obtained agreed reasonably well (Table III) . This calculated value of the maximal initial velocity of uptake is approximately six times the maximal rate of steady state taurocholate excretion into bile (16, 17) ; this finding indicates that uptake is probably not ratelimiting in the overall process of taurocholate excretion.
The maximal removal rate and the dose that correspond to half-maximal removal rate are only minimal estimates, since they are based upon the assumption that the injected material is dispersed along the whole length of the hepatic sinusoids at zero time, rather than limited to a concentration wave (3) . Moreover, in view of the very high extraction efficiency for taurocholate, and the possibility that the concentration of taurocholate decreases from the portal region to the centrolobular region, the value of k1 may be higher toward the central lobular zone than at the periphery of the lobule. Thus, it may be an oversimplification to refer to a single value of k18 for a given dose of taurocholate; however, with Hepatocellular Uptake of Taurocholate the methods currently available, this is probably the best estimate that can be obtained.
In addition to the carrier-mediated uptake, a passive diffusion of taurocholate into liver cells could theoretically be possible; however, in our experiments, the finding of a space of distribution of taurocholate that did not increase when the dose increased excludes an important contribution of diffusion. Finally, portal concentration of endogenous bile acids was not considered. To minimize their influence on our results, the dogs were fasted 24 h before the experiment on the assumption that most of the bile acid pool was stored in the gallbladder and thus excluded from the enterohepatic circulation during the experiments.
Theoretically, the carrier-mediated transport system for taurocholate could be located either in the sinusoidal membrane, or in the cytoplasm, as previously suggested for BSP through its binding to the Y and Z proteins (18), or both. At the moment, there is no evidence that Y and Z proteins may be involved in the hepatic uptake of taurocholate; in particular, taurocholate did not displace BSP from Y and Z fractions in vitro (except at very high doses) (18) . Our experiments cannot tell if the intracellular binding proteins play a role in the uptake process, and it is not possible to determine with the present method whether there is a passive transfer through the membrane followed by binding to a cytoplasmic carrier or whether the uptake process is mediated by a carrier located in the sinusoidal plasma membrane.
In conclusion, these studies show the applicability to the study of taurocholate uptake of a three-compartment model system with flow-limited distribution. This model allows the calculation of the initial extravascular space accessible to taurocholate, of the maximal initial transport capacity, and of the plasma concentration yielding half-maximal initial velocity. The results were thus considered to be consistent with the existence of a carriermediated transport system.
